Wells Fargo’s Neurotrope, Inc. Common NTRP Stock Holding History

Wells Fargo’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-128	Closed	–	–	7395
2020 Q3	$0	Buy	128 +61	+91%	+$70	﹤0.01%	7261
2020 Q2	$0	Buy	67 +1	+2%	+$1	﹤0.01%	7148
2020 Q1	$0	Buy	+66	New	+$72	﹤0.01%	7155
2019 Q4	–	Sell	-1,000	Closed	-$1K	–	6937
2019 Q3	$1K	Hold	1,000	–	–	﹤0.01%	6327
2019 Q2	$8K	Hold	1,000	–	–	﹤0.01%	5969
2019 Q1	$5K	Hold	1,000	–	–	﹤0.01%	5756
2018 Q4	$4K	Hold	1,000	–	–	﹤0.01%	6123
2018 Q3	$9K	Hold	1,000	–	–	﹤0.01%	6028
2018 Q2	$10K	Hold	1,000	–	–	﹤0.01%	5966
2018 Q1	$8K	Hold	1,000	–	–	﹤0.01%	5993
2017 Q4	$7K	Sell	1,000 -2,499	-71%	-$14.6K	﹤0.01%	6005
2017 Q3	$18K	Buy	3,499 +2,186	+166%	+$11.5K	﹤0.01%	5746
2017 Q2	$12K	Buy	1,313 +1,000	+319%	+$10.7K	﹤0.01%	5742
2017 Q1	$6K	Buy	+313	New	+$5.93K	﹤0.01%	6001

Other funds holding NTRP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Wells Fargo's NTRP Position: Q4 2020 in Review

Wells Fargo sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 128 shares.

Wells Fargo first reported a position in NTRP in Q1 2017 and held it in 14 quarters. The position peaked at $18K in Q3 2017. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

Wells Fargo reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
Wells Fargo sold 128 Neurotrope, Inc. Common shares in Q4 2020.
Wells Fargo first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 14 quarters.
Wells Fargo's Neurotrope, Inc. Common position peaked at $18K in Q3 2017.
1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.